These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1359593)

  • 1. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Neuropsychobiology; 1992; 26(1-2):37-42. PubMed ID: 1361969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):107-13. PubMed ID: 1352999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism.
    Roy A; DeJong J; Gold P; Rubinow D; Adinoff B; Ravitz B; Waxman R; Linnoila M
    Acta Psychiatr Scand; 1990 Jul; 82(1):44-8. PubMed ID: 1975969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
    Nemeroff CB; Bissette G; Akil H; Fink M
    Br J Psychiatry; 1991 Jan; 158():59-63. PubMed ID: 1673078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.
    Forman SD; Bissette G; Yao J; Nemeroff CB; van Kammen DP
    Schizophr Res; 1994 Apr; 12(1):43-51. PubMed ID: 8018584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH.
    Westrin A; Ekman R; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):135-43. PubMed ID: 11313159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH; Rubinow D; Gwirtsman HE; George DT; Jimerson DC; Gold PW
    Psychoneuroendocrinology; 1988; 13(3):265-72. PubMed ID: 2900533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF neuropeptide Y in alcoholics and normal controls.
    Roy A; Berrettini W; DeJong J; Adinoff B; Ravitz B; Linnoila M
    Psychiatry Res; 1990 Sep; 33(3):215-9. PubMed ID: 1978753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
    Nikisch G; Baumann P; Liu T; Mathé AA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1051-61. PubMed ID: 22008251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin releasing hormone levels in human cerebrospinal fluid in various neurologic diseases.
    Mitsuma T; Nogimori T; Sahashi K; Adachi K; Kihara M; Murakami K; Nakao N; Gonda M; Fujii K; Okabe Y
    Am J Med Sci; 1986 Mar; 291(3):164-7. PubMed ID: 3082203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid neuropeptides in dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Biol Psychiatry; 1992 Sep; 32(5):452-6. PubMed ID: 1486150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour rhythms of hypothalamic corticotropin-releasing hormone, thyrotropin-releasing hormone, growth hormone-releasing hormone and somatostatin in rats injected with Freund's adjuvant.
    Esquifino AI; Selgas L; Vara E; Arce A; Cardinali DP
    Biol Signals Recept; 1999; 8(3):178-90. PubMed ID: 10213846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
    Adinoff B; Anton R; Linnoila M; Guidotti A; Nemeroff CB; Bissette G
    Neuropsychopharmacology; 1996 Sep; 15(3):288-95. PubMed ID: 8873112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.